In the regression model, TNF-α, MCP-1, BMI, and HDL cholesterol emerged as significant predictors of AhR activity.<h4>Conclusions</h4>Our findings demonstrate that elevated plasma AhR agonist activity is associated with obesity, systemic inflammation, and metabolic dysregulation. The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.